Kestra Medical Technologies: general counsel Traci Umberger sold 100,000 shares

What happened

• The filing says Traci Umberger, general counsel and chief administrative officer, exercised options for 100,000 shares at $17.00 on Oct 21, 2026 (cost $1,700,000) and sold 100,000 shares that same day for total proceeds of $2,718,318 (96,404 shares at a weighted average $27.15 for $2,617,301; 3,596 shares at a weighted average $28.09 for $101,017). The filing also reports a derivative disposition of 100,000 shares at $0.00 on Oct 21, 2026.

Key details

• Transaction dates and prices: Oct 21, 2026 — exercised 100,000 shares at $17.00; sold 96,404 shares at a weighted average $27.15 and 3,596 shares at a weighted average $28.09.
• Sale price ranges: the 96,404-share sale ranged $26.8050 to $27.7927 (footnote F2); the 3,596-share sale ranged $27.8200 to $28.4200 (footnote F3).
• Plan: the filing says the exercise and sale were a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted Jul 21, 2026 (footnote F1).
• Options and vesting: the filing says it includes 395,919 fully vested options as of the filing date, with 45,081 options vesting in equal monthly installments through Mar 6, 2027 (footnote F4).
• Shares owned after the transaction: not specified in the filing.
• Filing date: filed Oct 22, 2026; no late filing indicator in the report.

Why it may matter

• The filing says options were exercised and shares were sold under a 10b5-1 plan, so the exercised shares were sold as part of a pre-arranged plan (i.e., sold at/near exercise rather than held).
• The filing shows both an option exercise (derivative transaction code M) and open-market sales (code S).
• The filing does not show why the insider traded or why the company acted.